Patent · US Active

Treatment of spondyloarthritis

US11717500B2 · kind B2 · utility

0Cited by

2References

17Claims

0Family size

Assignee

PHARMACYL AB · SE

Inventors

Anders Bjork · Bjärred, SE
Gunnar Hedlund · Lund, SE

Key dates

Filing date	Jan 26, 2021
Grant date	Aug 8, 2023
Priority date	—
Expiry date	Apr 23, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for the treatment a disease resulting from spondyloarthritis, such as axial spondyloarthritis, psoriatic arthritis and enteropathic arthritis, by administering, to a mammal in need of such treatment, a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.